Condition
Middle Aged Patients
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Sevoflurane
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 4 (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04154449UnknownPrimary
Effect of Intranasal Insulin on Postoperative Cognitive Dysfunction
NCT01705743Phase 4CompletedPrimary
Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG
NCT01662622Phase 4CompletedPrimary
Minimal Alveolar Concentration of Sevoflurane Inducing Isoelectric Electroencephalogram
Showing all 3 trials
Research Network
Common Treatments
- Sevoflurane2
- Sevofluranenitrous Oxide1
- Insulin1
Active Sponsors
- Huazhong University of Science and Technology2
- Minia University1
- National Natural Science Foundation of China1
- Ministry of Health, China1
Top Investigators
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Related Conditions
- General Anesthesia2
- Sevoflurane1